Barclays’s Nuvectra Corporation Common Stock NVTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-14
| Closed | – | – | 6753 |
|
|
2019
Q4 | $0 | Buy |
+14
| New | +$17 | ﹤0.01% | 7157 |
|
|
2019
Q3 | – | Sell |
-34,923
| Closed | -$117K | – | 7409 |
|
|
2019
Q2 | $117K | Buy |
34,923
+16,508
| +90% | +$104K | ﹤0.01% | 5576 |
|
|
2019
Q1 | $203K | Buy |
18,415
+11,169
| +154% | +$151K | ﹤0.01% | 4814 |
|
|
2018
Q4 | $118K | Sell |
7,246
-34,311
| -83% | -$656K | ﹤0.01% | 4934 |
|
|
2018
Q3 | $914K | Buy |
41,557
+40,537
| +3,974% | +$780K | ﹤0.01% | 3711 |
|
|
2018
Q2 | $21K | Sell |
1,020
-4,080
| -80% | -$68.8K | ﹤0.01% | 6172 |
|
|
2018
Q1 | $66K | Buy |
5,100
+4,741
| +1,321% | +$48.1K | ﹤0.01% | 5677 |
|
|
2017
Q4 | $3K | Buy |
+359
| New | +$3.77K | ﹤0.01% | 6761 |
|
|
2017
Q2 | – | Sell |
-69
| Closed | – | – | 7116 |
|
|
2017
Q1 | $0 | Buy |
+69
| New | +$472 | ﹤0.01% | 7113 |
|
|
2016
Q4 | – | Sell |
-66
| Closed | – | – | 6973 |
|
|
2016
Q3 | $0 | Sell |
66
-1,088
| -94% | -$7.47K | ﹤0.01% | 6909 |
|
|
2016
Q2 | $8K | Sell |
1,154
-24,383
| -95% | -$194K | ﹤0.01% | 5629 |
|
|
2016
Q1 | $127K | Buy |
+25,537
| New | +$137K | ﹤0.01% | 4186 |
|
Other funds holding NVTR
Barclays's NVTR Position: Q1 2020 in Review
Barclays sold out of Nuvectra Corporation Common Stock (NVTR) in Q1 2020, closing a stake of 14 shares.
Barclays first reported a position in NVTR in Q1 2016 and held it in 12 quarters. The position peaked at $914K in Q3 2018. 2 funds tracked by Wall St. Rank hold NVTR as of Q1 2020.
- Barclays reported no remaining Nuvectra Corporation Common Stock position as of Q1 2020 after selling out during the quarter.
- Barclays sold 14 Nuvectra Corporation Common Stock shares in Q1 2020.
- Barclays first reported a position in Nuvectra Corporation Common Stock in Q1 2016 and held it in 12 quarters.
- Barclays's Nuvectra Corporation Common Stock position peaked at $914K in Q3 2018.
- 2 funds tracked by Wall St. Rank held Nuvectra Corporation Common Stock as of Q1 2020.
Based on Barclays's 13F filing for Q1 2020, filed 13 May 2020.